Anebulo Pharmaceuticals (ANEB) Current Assets (2020 - 2025)
Anebulo Pharmaceuticals (ANEB) posted quarterly Current Assets of $9.3 million for Q4 2025, down 39.76% year-over-year from $15.4 million in Q4 2024, and down 11.97% quarter-over-quarter from $10.5 million in Q3 2025.
Anebulo Pharmaceuticals (ANEB) Current Assets (2020 - 2025) Analysis & Trends
Anebulo Pharmaceuticals (ANEB) has reported Current Assets for 5 consecutive years, with $9.3 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Assets fell 39.76% year-over-year to $9.3 million; the TTM figure through Dec 2025 stood at $9.3 million (down 39.76% YoY), while the FY2025 annual figure was $12.0 million, up 241.01% from the prior year.
- Current Assets eased to $9.3 million in Q4 2025 per ANEB's latest filing, from $10.5 million in the prior quarter.
- Across five years, Current Assets topped out at $15.4 million in Q4 2024 and bottomed at $2.0 million in Q3 2024.
- Historically, Current Assets has averaged $8.6 million across 4 years, with a median of $9.3 million in 2025.
- Annual changes were most pronounced in 2024 — Current Assets tumbled 69.94% — and 2025, when it surged 436.83%.
- Anebulo Pharmaceuticals' Current Assets stood at $3.9 million in 2021, then soared by 74.83% to $6.8 million in 2023, then soared by 125.86% to $15.4 million in 2024, then slumped by 39.76% to $9.3 million in 2025.
- Business Quant data shows ANEB's Current Assets at $9.3 million in Q4 2025, $10.5 million in Q3 2025, and $12.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.70 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.23 Bn | 60.05 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 60.16 Bn | 55.02 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.86 Bn | 28.55 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.24 Bn | 9.85 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 1.76 Bn |
| 10 | Anebulo Pharmaceuticals | 16.43 Mn | 16.43 Mn | - | 9.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.27 Mn |
| Sep 30, 2025 | 10.54 Mn |
| Jun 30, 2025 | 11.96 Mn |
| Mar 31, 2025 | 13.81 Mn |
| Dec 31, 2024 | 15.40 Mn |
| Sep 30, 2024 | 1.96 Mn |
| Jun 30, 2024 | 3.51 Mn |
| Mar 31, 2024 | 5.37 Mn |
| Dec 31, 2023 | 6.82 Mn |
| Jun 30, 2023 | 11.67 Mn |
| Mar 31, 2021 | 3.90 Mn |
| Jun 30, 2020 | 3.03 Mn |